Condition

Acute Ischemic Stroke (2)

Stroke, Ischemic (2)

Acute ST Elevation Myocardial Infarction (1)

Stroke, Acute (1)

Overall Status

Completed (2)

Recruiting (2)

Not yet recruiting (1)

Phase

phase 4 (2)

phase 2/phase 3 (1)

phase 3 (1)

Sponsor

Beijing Tiantan Hospital (1)

General Hospital of Shenyang Military Region (1)

Guangzhou Recomgen Biotech Co., Ltd. (1)

Xinqiao Hospital of Chongqing (1)

Xuanwu Hospital, Beijing (1)

Collaborator

Guangzhou Recomgen Biotech Co., Ltd. (2)

CSPC RECOMGEN PHARMACEUTICAL (GUANGZHOU) CO.,LTD (1)

Chinese Academy of Medical Sciences, Fuwai Hospital (1)

Peking University (1)

Intervention

rhtnk-tpa (5)

alteplase (1)

antiplatelet agents (1)

endovascular treatment (1)

rt-pa (1)

Study Documents

Intervention Type

drug (5)

other (1)

Funder Type

Other (4)

Industry (1)

Study Type

Interventional (4)

Observational (1)

rhtnk-tpa

Showing 1 - 5 of 5

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Acute Ischemic Stroke Trial (rhTNK-tPA, Antiplatelet Agents)

Not yet recruiting

Acute Ischemic Stroke

rhTNK-tPA
Antiplatelet Agents

(no location specified)

Mar 1, 2023

Stroke, Acute, Stroke, Ischemic Trial in China (rhTNK-tPA, Endovascular treatment)

Recruiting

Stroke, Acute
Stroke, Ischemic

rhTNK-tPA
Endovascular treatment

Chongqing, Chongqing, China
+4 more

Oct 15, 2022

Acute ST Elevation Myocardial Infarction Trial in Guangzhou (rhTNK-tPA, alteplase)

Completed

Acute ST Elevation Myocardial Infarction

rhTNK-tPA
alteplase

Guangzhou, Guangdong, China

Guangzhou Recomgen Biotech Co., Ltd.

May 19, 2022

INtravenous TNK for Acute isChemicsTroke in China

Recruiting

Stroke, Ischemic

rhTNK-tPA

Shenyang, China

Department of Neurology, General Hospital of Northern Theater Co

Jan 30, 2023

Acute Ischemic Stroke Trial in China (rt-PA, rhTNK-tPA)

Completed

Acute Ischemic Stroke

rt-PA
rhTNK-tPA

Hefei, Anhui, China
+60 more

Jan 13, 2023